Pain Management

Consider migraine screening for all women aged 20 to 50 years, suggests Ailani; you'll likely find a majority of them have migraine. More pearls follow.

Migraine-specific preventive therapies should be in the primary care toolbox, according to headache specialist Jessica Ailani, MD.

Migraine headache specialist and researcher Jessica Ailani, MD, fully supports primary care as the setting for the majority of the treatment for the disease.

Lifetime use of opioids for migraine was found to be higher than for triptan medications. Try these 10 questions on other OVERCOME findings.

Our panel of doctors and pharmacists introduce naloxone, an opioid antagonist, as an option when treating opioid abuse or overdose.

The panel explains the common challenges they find when trying to treat a patient with opioids.

Findings on use of acute and preventive migraine therapy continue to reveal gaps with far more patients eligible than the proportions using either type.

A panel of experts discuss the parameters of the opioid epidemic and the role fentanyl plays within it.

When choosing a migraine treatment for acute attack relief, the American Headache Society suggests following these steps.

The CDC is inviting public feedback on updated recommendations for opioid prescribing for the first time since the controversial 2016 iteration.

Is virtual reality a viable option for chronic pain management? A new scoping review suggests it has potential. Here, key findings for primary care.

The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.

Use of continuous glucose monitoring to assess time in target glucose range in T2D patients was evaluated in a systematic literature review covering ~14 000 participants.

Platelet-rich plasma, in theory, seems like a logical and potentially beneficial treatment for osteoarthritis. Our pain expert reviews 2 recent studies that are telling.

Intranasal CGRP inhibitor zavegepant met coprimary regulatory endpoints in pivotal phase 3 trial in adults with migraine; FDA submission planned for Q1 2022.

Primary care physicians noted increased stress among patients during the pandemic and worry that telehealth visits may have hidden signs of drug misuse.

In the first review of its kind, authors found encouraging evidence supporting the use of hypnosis for chronic neuropathic pain treatment. Find key results in our new slideshow.

The impact on sexual function of chronic pain conditions has received little research inquiry and requires much more focused clinical attention.

Complex regional pain syndrome is often a medical challenge. Try this in-depth quiz on the etiology, the differential diagnosis, and most effective therapies.

From etiology to treatment, get a quick review of the latest guidance for managing chronic pelvic pain in our new slideshow.

A neurologist and a rheumatologist sat down with Patient Care editors to talk about their focus on balance in the gut microbiome as an essential element of clinical care.

Few common pain conditions have been as vexing to both patients and physicians as phantom limb pain. In our new slideshow, get a primer on prevention, treatment, pharmacotherapy, and more.

A new study reveals that nearly three-quarters of medication organizer packages contain a drug class from which a single pill could be lethal for a child.

Many therapies have been studied as treatments for CRPS, including acupuncture and SNRIs. Which ones have been found effective? Scroll through our new slideshow to find out.

What do primary care physicians need to know about CRPS? In our new slideshow, get a primer on diagnostic criteria, suspicious symptoms, testing, and more.